SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-199136
Filing Date
2020-07-27
Accepted
2020-07-27 08:05:28
Documents
3
Period of Report
2020-07-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d85896d8k.htm 8-K 16736
2 EX-99.1 d85896dex991.htm EX-99.1 9148
3 GRAPHIC g85896logo.jpg GRAPHIC 8461
  Complete submission text file 0001193125-20-199136.txt   38790
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 201048490
SIC: 2834 Pharmaceutical Preparations